I9DN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arbutus Biopharma Corp

Watchlist Manager

Watchlist

Price: 3.67 EUR -3.17% Market Closed

Market Cap: €692.6m

A	Arbutus Biopharma Corp F:I9DN	CA
	Australian Oil Company Ltd ASX:AOK	AU
C	Consolidated Edison Inc XMUN:EDC	US
	Spark New Zealand Ltd NZX:SPK	NZ
	Ebusco Holding NV F:8J30	NL
	eDreams ODIGEO SA OTC:EDDRF	ES
M	Monitorapp Co Ltd KOSDAQ:434480	KR

Profitability Summary

Arbutus Biopharma Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

82%

Negative 3Y Average Operating Margin

-527%

Operating Margin is Increasing

-359% > 82%

Exceptional Net Margin

84%

Negative 3Y Average Net Margin

-538%

Net Margin is Increasing

-339% > 84%

Negative Free Cash Flow Margin

-14%

Negative 3Y Average Free Cash Flow Margin

-534%

Free Cash Flow Margin is Increasing

-390% > -14%

Exceptional ROE

90%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-367%

ROIC is Increasing

-177% > 162%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.